Chemical, biological, radiological and nuclear (CBRN) cluster

Array ( [0] => Array ( [value] => Recherche [safe] => Recherche [view] => Recherche ) )
Domaine de recherche :
Sécurité
Type de financement :
H2020
Type d'instrument :
Recherche & Innovation Action
Budget indicatif :
3.5M€
Budget total :
13.75M€
Code de l'appel : SEC-05-DRS-2016-2017
En savoir plus
À noter :
TRL visé: 
6 et +

Specific Challenge:

Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market.

Such synergies among companies are not frequent in the area of CBRN technologies, which is to the detriment of industrial competitiveness, and which limits considerably the offer made to the practitioners if one compares with the actual technological state-of-the-art.

Part b) (2017): Several RIA aiming at research and development of novel CBRN technologies and innovations identified in the above-mentioned catalogue will be selected by the European Commission. Each of these actions will be led by an SME. Each consortium implementing such a RIA must not only establish a consortium agreement among its members, but also a collaboration agreement with the participants in the CSA supported through Part a). Such a collaboration agreement must settle how the results from the RIA will be exploited and integrated into platforms managed by the CSA.

The outcome of the proposal is expected to lead to development up to Technology Readiness Level (TRL) 4 to 7 for the RIA under part b